Hemangioblastic derivatives from human induced pluripotent stem cells exhibit limited expansion and early senescence

Stem Cells

Volumn 28, Issue 4, 2010, Pages 704-712

  Feng, Qiang ^a   Lu, Shi Jiang ^a   Klimanskaya, Irina ^b   Gomes, Ignatius ^c   Kim, Dohoon ^d   Chung, Young ^a   Honig, George R ^c   Kim, Kwang Soo ^a,d   Lanza, Robert ^a,b  

^a Stem Cell and Regenerative Medicine International   (United States)

^b Advanced Cell Technology   (United States)

^c UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

^d MCLEAN HOSPITAL   (United States)

Author keywords

Differentiation; Embryonic stem cells; Endothelial differentiation; Hemangioblast; Hematopoietic cells; Pluripotent stem cells; Proliferation; Reprogramming

Indexed keywords

ACETYL LOW DENSITY LIPOPROTEIN; MATRIGEL;

APOPTOSIS; ARTICLE; BLAST CELL; CELL AGING; CELL CULTURE; CELL DIFFERENTIATION; CELL GROWTH; CELL STRUCTURE; CELL TRANSPORT; COLONY FORMING UNIT; CONTROLLED STUDY; EMBRYO; EMBRYONIC STEM CELL; ENDOTHELIUM CELL; ERYTHROID CELL; GROWTH RATE; HEMATOPOIETIC CELL; HUMAN; HUMAN CELL; PHENOTYPE; PLURIPOTENT STEM CELL; SENESCENCE; STEM CELL EXPANSION;

CELL AGING; CELL CULTURE TECHNIQUES; CELL DIFFERENTIATION; CELL LINE; CELL PROLIFERATION; HEMANGIOBLASTS; HUMANS; INDUCED PLURIPOTENT STEM CELLS; PHENOTYPE; TIME FACTORS;

EID: 77950995392     PISSN: 10665099     EISSN: None     Source Type: Journal    
DOI: 10.1002/stem.321     Document Type: Article

References (44)

1. Yu J, Vodyanik MA, Smuga-Otto K et al. Induced pluripotent stem cell lines derived from human somatic cells. Science 2007;318: 1917-1920.
2. Takahashi K, Tanabe K, Ohnuki M et al. Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 2007; 131:861-872. (Pubitemid 350138099)
3. Woltjen K, Michael IP, Mohseni P et al. piggyBac transposition reprograms fibroblasts to induced pluripotent stem cells. Nature 2009;458: 766-770.
4. Kaji K, Norrby K, Paca A et al. Virus-free induction of pluripotency and subsequent excision of reprogramming factors. Nature 2009;458: 771-775.
5. Yu J, Hu J, Smuga-Otto K et al. Human induced pluripotent stem cells free of vector and transgene sequences. Science 2009;324: 797-801.
6. Kim D, Kim CH, Moon JI et al. Generation of human induced pluripotent stem cells by direct delivery of reprogramming proteins. Cell Stem Cell 2009;4:472-476.
7. Zhou H, Wu S, Joo JY et al. Generation of induced pluripotent stem cells using recombinant proteins. Cell Stem Cell 2009;4:381-384.
8. Zhang J, Wilson GF, Soerens AG et al. Functional cardiomyocytes derived from human induced pluripotent stem cells. Circ Res 2009; 104:e30-e41.
9. Zhang D, Jiang W, Liu M et al. Highly efficient differentiation of human ES cells and iPS cells into mature pancreatic insulin-producing cells. Cell Res 2009;19:429-438.
10. Song Z, Cai J, Liu Y et al. Efficient generation of hepatocyte-like cells from human induced pluripotent stem cells. Cell Res 2009;19: 1233-1242.
11. Meyer JS, Shearer RL, Capowski EE et al. Modeling early retinal development with human embryonic and induced pluripotent stem cells. Proc Natl Acad Sci U S A 2009;106:16698-16703.
12. Buchholz DE, Hikita ST, Rowland TJ et al. Derivation of functional retinal pigmented epithelium from induced pluripotent stem cells. Stem Cells 2009;27:2427-2434.
13. Hirami Y, Osakada F, Takahashi K et al. Generation of retinal cells from mouse and human induced pluripotent stem cells. Neurosci Lett 2009;458:126-131.
14. Osakada F, Jin ZB, Hirami Y et al. In vitro differentiation of retinal cells from human pluripotent stem cells by small-molecule induction. J Cell Sci 2009;122:3169-3179.
15. Dimos JT, Rodolfa KT, Niakan KK et al. Induced pluripotent stem cells generated from patients with ALS can be differentiated into motor neurons. Science 2008;321:1218-1221.
16. Soldner F, Hockemeyer D, Beard C et al. Parkinson's disease patientderived induced pluripotent stem cells free of viral reprogramming factors. Cell 2009;136:964-977.
17. Choi K, Yu J, Smuga-Otto K et al. Hematopoietic and endothelial differentiation of human induced pluripotent stem cells. Stem Cells 2009;27:559-567.
18. Choi KD, Vodyanik MA, Slukvin II. Generation of mature human myelomonocytic cells through expansion and differentiation of pluripotent stem cell-derived lin-CD34+CD43+CD45+ progenitors. J Clin Invest 2009;119:2818-2829.
19. Ye Z, Zhan H, Mali P et al. Human induced pluripotent stem cells from blood cells of healthy donors and patients with acquired blood disorders. Blood 2009;114:5473-5480.
20. Lengerke C, Grauer M, Niebuhr NI et al. Hematopoietic development from human induced pluripotent stem cells. Ann N Y Acad Sci 2009; 1176:219-227.
21. Lu SJ, Feng Q, Caballero S et al. Generation of functional hemangioblasts from human embryonic stem cells. Nat Methods 2007;4: 501-509. (Pubitemid 46852076)
22. Lu SJ, Luo C, Holton K et al. Robust generation of hemangioblastic progenitors from human embryonic stem cells. Regen Med 2008;3: 693-704.
23. Lu SJ, Feng Q, Park JS et al. Biologic properties and enucleation of red blood cells from human embryonic stem cells. Blood 2008;112: 4475-4484.
24. Thomson JA, Itskovitz-Eldor J, Shapiro SS et al. Embryonic stem cell lines derived from human blastocysts. Science 1998;282:1145-1147.
25. Cowan CA, Klimanskaya I, McMahon J et al. Derivation of embryonic stem-cell lines from human blastocysts. N Engl J Med 2004;350: 1353-1356. (Pubitemid 38375373)
26. Klimanskaya I, Chung Y, Becker S et al. Human embryonic stem-cell lines derived from single blastomeres. Nature 2006;444:481-485. (Pubitemid 44809064)
27. Chung Y, Klimanskaya I, Becker S et al. Human embryonic stem cell lines generated without embryo destruction. Cell Stem Cell 2008;2: 113-117. (Pubitemid 351168713)
28. Mazumder S, Plesca D, Almasan A. Caspase-3 activation is a critical determinant of genotoxic stress-induced apoptosis. Methods Mol Biol 2008;414:13-21.
29. Bodnar AG, Ouellette M, Frolkis M et al. Extension of life-span by introduction of telomerase into normal human cells. Science 1998; 279:349-352. (Pubitemid 28063364)
30. Klimanskaya I, Hipp J, Rezai KA et al. Derivation and comparative assessment of retinal pigment epithelium from human embryonic stem cells using transcriptomics. Cloning Stem Cells 2004;6:217-245. (Pubitemid 39391307)
31. Murry CE, Keller G. Differentiation of embryonic stem cells to clinically relevant populations: Lessons from embryonic development. Cell 2008;132:661-680. (Pubitemid 351260059)
32. Taura D, Sone M, Homma K et al. Induction and isolation of vascular cells from human induced pluripotent stem cells-brief report. Arterioscler Thromb Vasc Biol 2009;29:1100-1103.
33. Taura D, Noguchi M, Sone M et al. Adipogenic differentiation of human induced pluripotent stem cells: Comparison with that of human embryonic stem cells. FEBS Lett 2009;583:1029-1033.
34. Chin MH, Mason MJ, Xie W et al. Induced pluripotent stem cells and embryonic stem cells are distinguished by gene expression signatures. Cell Stem Cell 2009;5:111-123.
35. Pick M, Stelzer Y, Bar-Nur O et al. Clone and gene specific aberrations of parental imprinting in human induced pluripotent stem cells. Stem Cells 2009;27:2686-2690.
36. Doi A, Park IH, Wen B et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat Genet 2009;41:1350-1353.
37. Li Y, Zeng H, Xu RH et al. Vaccination with human pluripotent stem cells generates a broad spectrum of immunological and clinical response against colon cancer. Stem Cells 2009;27:3103-3111.
38. Kang L, Wang J, Zhang Y et al. iPS cells can support full-term development of tetraploid blastocyst-complemented embryos. Cell Stem Cell 2009;5:135-138.
39. Zhao XY, Li W, Lv Z et al. iPS cells produce viable mice through tetraploid complementation. Nature 2009;461:86-90.
40. Boland MJ, Hazen JL, Nazor KL et al. Adult mice generated from induced pluripotent stem cells. Nature 2009;461:91-94.
41. Hanna J, Wernig M, Markoulaki S et al. Treatment of sickle cell anemia mouse model with iPS cells generated from autologous skin. Science 2007;318:1920-1923.
42. Hong H, Takahashi K, Ichisaka T et al. Suppression of induced pluripotent stem cell generation by the p53-p21 pathway. Nature 2009;460: 1132-1135.
43. West JA, Viswanathan SR, Yabuuchi A et al. A role for Lin28 in primordial germ-cell development and germ-cell malignancy. Nature 2009;460:909-913.
44. Viswanathan SR, Powers JT, Einhorn W et al. Lin28 promotes transformation and is associated with advanced human malignancies. Nat Genet 2009;41:843-848.